Cyclic adhesion inhibitors
    1.
    发明公开
    Cyclic adhesion inhibitors 失效
    环状粘附抑制剂

    公开(公告)号:EP0578083A3

    公开(公告)日:1994-08-03

    申请号:EP93110232.1

    申请日:1993-06-26

    申请人: MERCK PATENT GmbH

    CPC分类号: C07K14/75 A61K38/00 C07K14/78

    摘要: Pharmaceutical compositions comprising at least one cyclopeptide of formulae I (a)-(r)
    (a) cyclo(-Arg-Gly-Asp-D-Phe-Val-Ala); (b) cyclo(-Arg-Gly-Asp-D-Phe-Leu-Ala); (c) cyclo(-Arg-Gly-Asp-Phe-Val-D-Ala); (d) cyclo(-Arg-Gly-Asp-Phe-Leu-D-Ala); (e) cyclo(-Arg-Gly-Asp-D-Phe-Val-Gly); (f) cyclo(-Arg-Gly-Asp-D-Phe-Leu-Gly); (g) cyclo(-D-Arg-Gly-Asp-Phe-Val-Ala); (h) cyclo(-D-Arg-Gly-Asp-Phe-Val-Gly; (i) cyclo(-Arg-Gly-Asp-Phe-Pro-Gly); (j) cyclo(-Arg-Gly-Asp-Phe-D-Pro-Gly); (k) cyclo(-Arg-Gly-Asp-Phe-Pro-Ala); (l) cyclo(-Arg-Gly-Asp-Phe-D-Pro-Ala); (m) cyclo(-D-Arg-Gly-Asp-Phe-Val); (n) cyclo(-Arg-D-Ala-Asp-Phe-Val); (o) cyclo(-Arg-Gly-Asp-D-Phe-Val); (p) cyclo(-Arg-Ala-Asp-D-Phe-Val); (q) cyclo(-Arg-Gly-Asp-Phe-D-Val; (r) cyclo(-Arg-Gly-D-Asp-Phe-Val); or a salt thereof are useful as cell adhesion inhibitors.

    摘要翻译: 包含至少一种式I(a) - (r)(a)环(-Arg-Gly-Asp-D-Phe-Val-Ala)的环肽的药物组合物; (b)环(-Arg-Gly-Asp-D-Phe-Leu-Ala); (c)环(-Arg-Gly-Asp-Phe-Val-D-Ala); (d)环(-Arg-Gly-Asp-Phe-Leu-D-Ala); (e)环(-Arg-Gly-Asp-D-Phe-Val-Gly); (f)环(-Arg-Gly-Asp-D-Phe-Leu-Gly); (g)环(-D-Arg-Gly-Asp-Phe-Val-Ala); (h)环(-D-Arg-Gly-Asp-Phe-Val-Gly;(i)环(-Arg-Gly-Asp-Phe- Pro- Gly);(j)环(-Arg- (-Arg-Gly-Asp-Phe-D-Pro-Ala);(k)环(-Arg-Gly-Asp-Phe-Pro-Ala); (-d-Arg-Gly-Asp-Phe-Val);(n)环(-Arg-D-Ala-Asp-Phe- (-Arg-Gly-Asp-Phe-Val);(p)环(-Arg-Ala-Asp-D-Phe- Arg-Gly-D-Asp-Phe-Val)或其盐作为细胞粘附抑制剂是有用的。

    Cyclic adhesion inhibitors
    2.
    发明公开
    Cyclic adhesion inhibitors 失效
    ZyklischeAdhäsionsinhibitoren。

    公开(公告)号:EP0578083A2

    公开(公告)日:1994-01-12

    申请号:EP93110232.1

    申请日:1993-06-26

    申请人: MERCK PATENT GmbH

    CPC分类号: C07K14/75 A61K38/00 C07K14/78

    摘要: Pharmaceutical compositions comprising at least one cyclopeptide of formulae I (a)-(r)

    (a) cyclo(-Arg-Gly-Asp-D-Phe-Val-Ala);
    (b) cyclo(-Arg-Gly-Asp-D-Phe-Leu-Ala);
    (c) cyclo(-Arg-Gly-Asp-Phe-Val-D-Ala);
    (d) cyclo(-Arg-Gly-Asp-Phe-Leu-D-Ala);
    (e) cyclo(-Arg-Gly-Asp-D-Phe-Val-Gly);
    (f) cyclo(-Arg-Gly-Asp-D-Phe-Leu-Gly);
    (g) cyclo(-D-Arg-Gly-Asp-Phe-Val-Ala);
    (h) cyclo(-D-Arg-Gly-Asp-Phe-Val-Gly;
    (i) cyclo(-Arg-Gly-Asp-Phe-Pro-Gly);
    (j) cyclo(-Arg-Gly-Asp-Phe-D-Pro-Gly);
    (k) cyclo(-Arg-Gly-Asp-Phe-Pro-Ala);
    (l) cyclo(-Arg-Gly-Asp-Phe-D-Pro-Ala);
    (m) cyclo(-D-Arg-Gly-Asp-Phe-Val);
    (n) cyclo(-Arg-D-Ala-Asp-Phe-Val);
    (o) cyclo(-Arg-Gly-Asp-D-Phe-Val);
    (p) cyclo(-Arg-Ala-Asp-D-Phe-Val);
    (q) cyclo(-Arg-Gly-Asp-Phe-D-Val;
    (r) cyclo(-Arg-Gly-D-Asp-Phe-Val);
    or a salt thereof are useful as cell adhesion inhibitors.

    摘要翻译: 包含至少一种式I(a) - (r)(a)环(-Arg-Gly-Asp-D-Phe-Val-Ala)的环肽的药物组合物; (b)环(-Arg-Gly-Asp-D-Phe-Leu-Ala); (c)环(-Arg-Gly-Asp-Phe-Val-D-Ala); (d)环(-Arg-Gly-Asp-Phe-Leu-D-Ala); (e)环(-Arg-Gly-Asp-D-Phe-Val-Gly); (f)环(-Arg-Gly-Asp-D-Phe-Leu-Gly); (g)环(-D-Arg-Gly-Asp-Phe-Val-Ala); (i)环(-Arg-Gly-Asp-Phe-Pro-Gly);(j)环(-Arg-Gly-Asp-Phe-Val-Gly -Phe-D-Pro-Gly);(k)环(-Arg-Gly-Asp-Phe-Pro-Ala);(1)环(-Arg-Gly-Asp-Phe-D-Pro-Ala) (-Arg-D-Ala-Asp-Phe-Val);(o)环(-Arg-Gly-Asp-Phe-Val);(n) D-Phe-Val);(p)环(-Arg-Ala-Asp-D-Phe-Val);(q)环(-Arg-Gly-Asp-Phe-D-Val;(r) Arg-Gly-D-Asp-Phe-Val);或其盐可用作细胞粘附抑制剂。